Sleep scientists describe how slow-wave sleep can act as a protective factor against memory decline in those with existing high amounts of Alzheimer’s disease pathology—a potentially significant advance that could help alleviate some of dementia’s most devastating outcomes.
Read More
Chronic circadian disruption—such as that experienced by rotating shift workers—has been linked to increased cancer risk, but the biological mechanisms that underpin this risk have remained largely unknown.
Read More
The AMAZE Program will encompass two double-blind phase 3 trials investigating Quilience versus placebo in adult patients with narcolepsy, commencing this summer at multiple US sites.
Read More
Inspire Medical Systems Inc, a medical technology company focused on the development of solutions...
Read More
The approval was supported by phase 3 results that demonstrated Quviviq improved sleep onset, sleep maintenance, and self-reported total sleep time in adults with insomnia.
Read More